Surveillance track

Monitor drug-event signal evidence with explicit protocol scope, source provenance, coding/QC review, and human clinical assessment before any regulatory claim.

Alerting

Thresholds, quiet periods, disproportionality context, and audit records help teams triage material pharmacovigilance signal changes without treating heuristics as confirmed causality.